Analysis on whether ceritinib/ceritinib (Zanda) can be stopped at will while taking the medicine

Ceritinib (Ceritinib, trade name: Zykadia) is an oral small molecule ALKinhibitors are mainly used to treat patients with ALK-positive advanced or metastatic non-small cell lung cancer (NSCLC). By inhibiting ALK tyrosine kinase activity, ceritinib can block cancer cell proliferation signals, thereby inhibiting tumor growth. Since its mechanism of action is closely related to tumor dependence, long-term and regular medication is crucial to maintaining the therapeutic effect.

Ceritinib is a targeted, sustained-acting drug. Random discontinuation of the drug may lead to a sudden drop in blood concentration, leading to rapid tumor recurrence or an increased risk of drug resistance. Especially for patients with advanced or metastatic lung cancer, treatment interruption may shorten progression-free survival (PFS) and overall survival (OS). Therefore, patients should not stop taking the medicine on their own or adjust the dosage at will.

In clinical practice, drug discontinuation or dose adjustment is usually only done when serious adverse reactions occur or when concomitant medication causes interactions, and is guided by doctors based on the patient's specific conditions. For example, when abnormal liver function, persistent diarrhea, or prolongation of the QT interval on the electrocardiogram occurs, the doctor may temporarily stop the drug or reduce the dose, and then resume the original dose after the symptoms are relieved. Patients should strictly follow the doctor's instructions and never decide to stop taking the medicine on their own.

In order to ensure efficacy and safety, patients should take ceritinib regularly every day and follow the prescribed full course of treatment. If it needs to be interrupted for special reasons, it must be done under the guidance of a doctor, while monitoring blood routine, liver function, electrocardiogram and other indicators. Correct medication management can not only maximize the efficacy of drugs, but also reduce the risk of side effects and ensure the stability and safety of long-term treatment for patients.

Reference materials:https://www.drugs.com/